Wealthcare Advisory Partners LLC Editas Medicine, Inc. Transaction History

Wealthcare Advisory Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 29, 2020	SELL	$18.5 - $34.34 $2,590 - $4,807	-140 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$27.65 - $38.39 $1,797 - $2,495	-65 Reduced 31.71%	140 $4,000
Q2 2018 Aug 14, 2018	BUY	$31.4 - $41.01 $4,396 - $5,741	140 Added 215.38%	205 $7,000
Q4 2017 Feb 14, 2018	BUY	$21.89 - $31.34 $1,422 - $2,037	65	65 $2,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.